The Eosinophil in Inflammatory Bowel Disease

References

• Saverymuttu S H, Camilleri M, Rees H, Lavender J P, Hodgson H JF, Chadwick V S. Indium-111 granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. Gastroenterology 1986; 90: 1121–1128
   PubMed Web of Science ®Google Scholar
• Stein D T, Gray G M, Gregory P B, Anderson M, Goodwin D A, McDougall I R. Location and activity of ulcerative and Crohn's colitis by indium-111 leukocyte scan. Gastroenterology 1983; 84: 388–393
   PubMed Web of Science ®Google Scholar
• Shiratora Y, Aoki S, Takada H, et al. Oxygen-derived free radical generating capacity of polymorphonucleated cells in patients with ulcerative colitis. Digestion 1989; 44: 163–171
   PubMed Web of Science ®Google Scholar
• Nielsen O H. In vitro studies on the significance of arachidonate metabolism and other oxidative processes in the inflammatory response of human neutrophils and macrophages with special reference to chronic inflammatory bowel disease. Scand J Gastroenterol 1988; 23(Suppl 150)1–22
   PubMedGoogle Scholar
• Gleich G J, Loegering D A, Kueppers F, Bayuaj S P, Mann K G. Physiochemical and biological properties of major basic protein from the guinea pig eosinophil granules. J Exp Med 1974; 1403: 313–317
   Google Scholar
• Gleich G J, Frigas E, Loegering D A, Wassom D L, Steinmuller D. Cytotoxic properties of eosinophil major basic protein. J Immunol 1979; 123: 2925–2927
   PubMed Web of Science ®Google Scholar
• Olsson I, Venge P. Cationic proteins of human granulocytes. I. Isolation of the cationic protein of granules of leukaemic myeloid cells. Scand J Haematol 1972; 9: 201–214
   Google Scholar
• Ehrlich P, Lazarus A. The eosinophil. Histology of the blood: normal and pathological, W Myers. Cambridge University Press, London 1900; 216
   Google Scholar
• Spry C JF, Davies J, Tai P-C, Olsen E GF, Oakley C M. Clinical features of fifteen patients with the hypereosinophilic syndrome. Q J Med 1983; 205: 1–2
   Google Scholar
• Caldwell J H, Sharma H M, Hurtubise P E, Colwell D L. Eosinophilic gastroenteritis in extreme allergy. Immunopathological comparison with nonallergic gastrointestinal disease. Gastroenterology 1979; 77: 560–564
   PubMedGoogle Scholar
• Keshavarzian A, Saverymuttu S H, Tai P-C, et al. Activated eosinophils in familial eosinophilic gastroenteritis. Gastroenterology 1985; 88: 1041–1049
   PubMedGoogle Scholar
• Fukuda T, Adutsu I, Numao T, Motojuna S, Makino S. The eosinophil in asthma. Triangle 1988; 27: 103–112
   Google Scholar
• Lewis D M, Loegering D A, Gleich C J. Isolation and partial characterization of a major basic protein from rat eosinophil granules. Proc Soc Exp Biol Med 1976; 152: 512–515
   PubMedGoogle Scholar
• Gleich G J, Loegering D A, Mann K A, Maldonado J E. Comparative properties of Charcot-Leyden crystal protein and major basic protein from human eosinophils. J Clin Invest 1976; 57: 633–635
   PubMed Web of Science ®Google Scholar
• Olsson I, Venge P, Sptiznagel J K, Lehrer R I. Arginine-rich cationic proteins in human eosinophil granules. Comparison of constituents of eosinophilic and neutrophilic leukocytes. Lab Invest 1977; 36: 493–500
   PubMed Web of Science ®Google Scholar
• Carlson M GC, Peterson C GB, Venge P. Human eosinophil peroxidase: purification and characterization. J Immunol 1985; 134: 1875–1879
   PubMed Web of Science ®Google Scholar
• Durack D T, Ackerman S T, Loegering D A, Gleich G J. Purification of human eosinophil derived neurotoxin. Proc Natl Acad Sci USA 1981; 78: 5165–5169
   PubMed Web of Science ®Google Scholar
• Gleich G J, Loegering D A, Bell M P, Checkel J K, Ackerman S T, McKean D J. Biochemical and functional similarities between human eosinophil derived neurotoxin and eosinophilic cationic protein: Homology with ribonuclease. Proc Natl Acad Sci USA 1986; 83: 3146–3150
   PubMed Web of Science ®Google Scholar
• Parker C W. Mediators: release and function. Fundamental immunology, W E Paul. Raven Press, New York 1984; 707–712
   Google Scholar
• Ackerman S J, Loegering D A, Venge P, et al. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J Immunol 1983; 131: 2977–2982
   PubMed Web of Science ®Google Scholar
• Dvorak A M, Letourneau L, Login G R, Weller P F, Ackerman S J. Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. Blood 1988; 72: 150–158
   PubMedGoogle Scholar
• Kay A B, Anwar A RE. Eosinophil surface receptors. The eosinophil in health and disease, A AF Mahmond, K F Austen. Grune and Stratton, New York 1980; 207–30
   Google Scholar
• Phillips S M, Colley D G. Immunologic aspects of host response to schistosomiasis: resistance immunopathology and eosinophil involvement. Prog Allergy 1978; 24: 49–182
   PubMedGoogle Scholar
• Weller P F, Dvorak A M. Arachidonic acid incorporation by cytoplasmic lipid bodies of human eosinophils. Blood 1985; 65: 1269–1274
   PubMedGoogle Scholar
• Dvorak A M, Dvorak H F, Peters S P, et al. Lipid bodies: cytoplasmic organelles important to arachi-donate metabolism in macrophages and mast cells. J Immunol 1983; 131: 2965–2976
   PubMed Web of Science ®Google Scholar
• Dvorak A M, Furitsu T, Letourneau L, Ishizaka T, Ackerman S J. Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human in-terleukin-5. I. Piecemeal degranulation of specific granules and distribution of Charcot-Leydon crystals protein. Am J Pathol 1991; 138: 69–82
   PubMed Web of Science ®Google Scholar
• Venge P, Dahl R, Hallgren R, Olsson I. Cationic proteins of human eosinophils and their role in the inflammatory reaction. The eosinophil in health and disease, A AF Mahmoud, K F Austen. Grune and Stratton, New York 1980; 1131–1142
   Google Scholar
• Frigas E, Loegering D A, Gleich G J. Cytotoxic effects of guinea pig major basic protein on tracheal epithelium. Lab Invest 1980; 42: 35–43
   PubMed Web of Science ®Google Scholar
• Spry C JF. Eosinophil structure, constituents, and metabolism in eosinophils, a comprehensive review and guide to the scientific and medical literature. Oxford University Press, Oxford 1988; 48–65
   Google Scholar
• Gleich G J, Frigas E, Loegering D A, Wassom D L, Steinmuller D. Cytotoxic properties of the eosinophil major basic protein. J Immunol 1979; 123: 2925–2927
   PubMed Web of Science ®Google Scholar
• O'Donnell M C, Ackerman S J, Gleich G J, Thomas L L. Activation of basophil and mast cell histamine release by eosinophil granule major basic protein. J Exp Med 1983; 157: 1981–1991
   PubMed Web of Science ®Google Scholar
• Dvorak A M, Letourneau L, Weller P F, Ackerman S J. Ultrastructural localization of Charcot-Leyden crystal protein (lysophospholipase) to intracyto-plasmic crystals in tumor cells of primary solid and papilary neoplasm of the pancreas. Lab Invest 1990; 62: 608–615
   PubMed Web of Science ®Google Scholar
• Weller P F, Goetzl E J, Austen K F. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci USA 1980; 77: 7740–7743
   Google Scholar
• Burke L A, Crea A EG, Wilkinson J RW, Arm J P, Spur B W, Lee T H. Comparison of the generation of platelet-activating factor and leukotriene C4 in human eosinophils stimulated by unopsinized zymosan and by the calcium ionophore A23187: the effects of nedocromil sodium. J Allergy Clin Immunol 1990; 85: 26–35
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Weller P F, Sunn F F. The regulation of human eosinophil function by endogenous mono-hydroxyeicosatetraenoic acid (HETE's). J Immunol 1980; 124: 926–933
   PubMedGoogle Scholar
• Goetzl E J. Mediators of immune hypersensitivity derived from arachidonic acid. N Engl J Med 1980; 303: 822–825
   PubMed Web of Science ®Google Scholar
• Bruijnzeel P LB. Contribution of eosinophil-derived mediators in asthma. Int Arch Allergy Appl Immunol 1989; 90: 57–63
   PubMedGoogle Scholar
• Tauber A I, Goetzl E J, Babior B M. Unique characteristics of superoxide production by human eosinophils in eosinophilic sites. Inflammation 1979; 3: 261–272
   PubMedGoogle Scholar
• Capron M, Rousslaux J, Mazingue C, Bazin H, Capron A. Rat mast cell-eosinophil interaction in antibody dependent eosinophil cytotoxicity to schistosoma mansoni schistosomula. J Immunol 1978; 121: 2518–2525
   PubMed Web of Science ®Google Scholar
• Dvorak A M, Klebanoff S J, Henderson W R, Man-ahan R A, Pyne K, Galli S J. Vesicular uptake of eosinophil peroxidase by guinea pig basophils and by cloned mouse mast cells and granule-containing lymphoid cells. Am J Pathol 1985; 118: 425–436
   PubMedGoogle Scholar
• Ogawa H, Kunkel S L, Fantone J L, Ward P A. Digestion of the fifth component of complement by eosinophil lysosomal enzymes: production of eosinophil specific chemotactic activity. Virchows Arch [Cell Pathol] 1981; 38: 149–157
   Google Scholar
• Rand T H, Clanton J A, Colley D G. Arachidonic acid metabolism in the murine eosinophil. III. Effect of nonsteroid anti-inflammatory drugs on lymphokine-directed eosinophil migration in vivo. J Immunol 1983; 130: 1356–1358
   Google Scholar
• Czarnetzki B M, Rosenbach T. Chemotaxis of human neutrophils and eosinophils towards leukotriene B4 and its 20-ω-oxidation products in vitro. Prostaglandins 1986; 31: 851–858
   PubMedGoogle Scholar
• Wadee A A, Anderson R, Sher R. In vitro effects of histamine on eosinophil migration. Int Arch Allergy Appl Immunol 1980; 63: 322–329
   PubMedGoogle Scholar
• Prin L, Capron M, Tonnel A B, Bletry O, Capron A. Heterogeneity of human peripheral blood eosinophil: variability in cell density and cytotoxic ability in relation to the level and the origin of hypereosinophilia. Int Arch Allergy Appl Immunol 1983; 72: 336–346
   PubMedGoogle Scholar
• Rothenberg M E, Owen W F, Silberstein D S, Soberman R J, Austin K F, Stevens R L. Eosinophils cocultured with endothelial cells have increased survival and functional properties. Science 1987; 237: 645–647
   PubMed Web of Science ®Google Scholar
• Ishizaka T, Saito H, Hatake K, et al. Preferential differentiation of inflammatory cells by recombinant human interleukins. Int Arch Allergy Appl Immunol 1989; 88: 46–49
   PubMedGoogle Scholar
• Dvorak A M, Saito H, Estrella P, Kissel S, Arai N, Ishizaka T. Ultrastructure of eosinophils and basophils stimulated to develop in human cord blood mononuclear cell cultures containing recombinant human interleukin-5 or interleukin-3. Lab Invest 1989; 61: 116–210
   PubMed Web of Science ®Google Scholar
• Wang J M, Rambaldi A, Biondi A, Chen Z G, Sanderson C J, Mantovani A. Recombinant human interleukin-5 is a selective eosinophil chemoattractant. Eur J Immunol 1989; 19: 701–705
   PubMed Web of Science ®Google Scholar
• Etienne A, Soulard C, Thonier F, Braquet P. Modulation by drugs of eosinophil recruitment induced by immune challenge in rat: Possible role of interleukin-5 and platelet-activating factor. Int Arch Allergy Appl Immunol 1989; 88: 216–221
   PubMedGoogle Scholar
• Kimani G, Tonnesen M C, Henson P M. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. J Immunol 1988; 140: 3161–3166
   PubMed Web of Science ®Google Scholar
• Wardlaw A J, Moqbel R, Cromwell O, Kay A B. Platelet-activating factor. A potent chemotactic and chemokinetic factor for eosinophils. J Clin Invest 1986; 78: 1701–1710
   PubMed Web of Science ®Google Scholar
• Wallace J L. Release of platelet-activating factor (PAF) and accelerated healing induced by a PAF antagonist in an animal model of chronic colitis. Can J Physiol 1988; 66: 422–425
   PubMed Web of Science ®Google Scholar
• Ogawa H, Kunkel S L, Fantone J C, Ward P A. Comparative study of eosinophil and neutrophil chemo-taxis and enzyme release. Am J Pathol 1981; 105: 149–155
   PubMedGoogle Scholar
• Goetzl E J, Woods J M, Gorman R R. Stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12-L-hydroxy-5,8,10,12-eicosatetraenoic acid (HETE). J Clin Invest 1977; 59: 179–183
   PubMed Web of Science ®Google Scholar
• Krogel C, Yukawa T, Dent G, Chung K F, Barnes P J. Platelet-activating factor induces eosinophil peroxidase release from human eosinophils. Immunology 1988; 64: 559–571
   PubMedGoogle Scholar
• Krogel C, Yukawa T, Dent G, Venge P, Chung K F, Barnes P J. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989; 142: 3519–3526
   Google Scholar
• Whitcomb E A, Dinarello C A, Pincus S H. Differential effects of interleukin-lor and interleukin-1α on human peripheral blood eosinophils. Blood 1989; 73: 1904–1908
   PubMedGoogle Scholar
• Caldwell J H, Mekhjian H J, Hurtubise P E, Beman F M. Eosinophilic gastroenteritis with obstruction. Immunological studies of seven patients. Gastroenterology 1978; 74: 825–829
   PubMedGoogle Scholar
• Moore D, Lichtman S, Lentz J, Stringer D, Sherman P. Eosinophilic gastroenteritis presenting in an adolescent with isolated colonic involvement. Gut 1986; 27: 1219–1222
   PubMedGoogle Scholar
• Klein N C, Hargrove M D, Sleisenger M H, Jefferies G H. Eosinophilic gastroenteritis. Medicine 1970; 49: 299–311
   PubMed Web of Science ®Google Scholar
• Walls R S, Beesen P B. Mechanism of eosinophilia. VIII. Importance of local cellular reactions in stimulating eosinophil production. Clin Exp Immunol 1972; 12: 111–117
   PubMedGoogle Scholar
• Torisu M, Yoshida T, Cohen S, Ward P A. Lymphocyte-derived eosinophil chemotactic factor. J Immunol 1973; 111: 1450–1459
   PubMedGoogle Scholar
• Goldman H, Proujansky R. Allergic proctitis and gastroenteritis in children. Clinical and mucosal biopsy features in 53 cases. Am J Surg Pathol 1986; 10: 75–86
   PubMed Web of Science ®Google Scholar
• Tai P-C, Spry C JF, Peterson C, Venge P, Olsson I. Monoclonal antibodies distinguish between storage and secretes forms of ECP. Nature 1984; 309: 182–184
   PubMed Web of Science ®Google Scholar
• Aiuti F, Paganelli R. Food allergy and gastrointestinal diseases. Ann Allergy 1983; 51: 275–280
   PubMedGoogle Scholar
• Shiner M, Ballard J, Smith M E. The small-intestinal mucosa in cow's milk allergy. Lancet 1975; 136–140
   PubMedGoogle Scholar
• Beeken W, Northwood I, Beleveau C, Gump D. Phagocytes in cell suspensions of human colon mucosa. Gut 1987; 28: 976–980
   PubMedGoogle Scholar
• Wright R, Truelove S C. Circulating and tissue eosinophils in ulcerative colitis. Am J Dig Dis 1966; 11: 831–846
   PubMedGoogle Scholar
• Sarin S K, Malhotra V, Sen Gupta S, Karol A, Gaur S K, Anand B S. Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 1978; 32: 363–367
   Google Scholar
• Willoughby C P, Piris J, Truelove S C. Tissue eosino phils in ulcerative colitis. Scand J Gastroenterol 1979; 14: 395–399
   PubMedGoogle Scholar
• Dvorak A M. Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: cytotoxic potential in Crohn's disease. J Immunol 1980; 125: 460–462
   PubMedGoogle Scholar
• Hallgren R, Colombel J F, Dahl R, et al. Neutrophil and eosinophil involvement of the small bowel in patients with celiac disease and Crohn's disease: studies on the secretion rate and immunohisto-chemical localization of granulocyte granule constituents. Am J Med 1989; 86: 56–64
   PubMed Web of Science ®Google Scholar
• Dvorak A M, Monahan R A, Osage J E, Dickersin G R. Crohn's disease: transmission electron microscopic studies. I. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils and the microvasculature. Hum Pathol 1980; 11: 606–619
   PubMedGoogle Scholar
• Henderson W R, Chi E Y, Klebanoff S J. Eosinophil peroxidase-induced mast cell secretion. J Exp Med 1980; 152: 265–276
   PubMed Web of Science ®Google Scholar
• Dvorak A M. Ultrastructure of human gastrointestinal system. Interactions among mast cells, eosinophils, nerves and muscle in human disease. Effects of immune cells and inflammation on smooth muscle and enteric nerves, W J Shape, S Collins. CRC Press, Inc., Boca Raton, Fla. 1991; 150–158
   Google Scholar
• Dvorak A M, Osage J E, Manaham R A, Dickerson G R. Crohn's disease: transmission elestron microscope studies. HI. Target tissues. Proliferation of and injury to smooth muscle and the autonomic nervous system. Hum Pathol 1980; 11: 620–627
   PubMed Web of Science ®Google Scholar
• Durak D T, Sumi S M, Klebanoff S J. Neurotoxicity of human eosinophils. Proc Natl Acad Sci USA 1979; 76: 1443–1450
   PubMedGoogle Scholar
• Dvorak A M, Silen W. Differentiation between Crohn's disease and other inflammatory conditions by electron microscopy. Ann Surg 1985; 53: 201–215
   Google Scholar
• Mazurek N, Pecht I, Teichberg V I, Blumberg S. The role of N-terminal tetrapeptide in the histamine releasing action of substance P. Neuropharmacology 1981; 20: 1025–1027
   PubMed Web of Science ®Google Scholar
• Goetzl E J, Chernov T, Renold F, Payen D G. Neuropeptide regulation of the expression of hypersensitivity. J Immunol 1985; 135(suppl)802–805
   Google Scholar
• Payan D G, Brewster D R, Goetzl E J. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131: 1613–1616
   PubMed Web of Science ®Google Scholar
• DeSimone C, Ferrari M, Ferrarelli G, Rumi C, Pugnaloni L, Sorice F. The effects of substance P on human eosinophils receptors and functions. Ann NY Acad Sci 1988; 527: 226–232
   Google Scholar
• Lake A M, Stitzel A E, Urmson J R, Walker W A, Splitzer R E. Complement alterations in inflammatory bowel disease. Gastroenterology 1979; 76: 1374–1379
   PubMed Web of Science ®Google Scholar
• Hodgson H JF, Potter B J, Jewell D P. C3 metabolism in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1977; 28: 490–495
   PubMed Web of Science ®Google Scholar
• Sharon P, Stenson W F. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease. Gastroenterology 1984; 86: 453–460
   PubMed Web of Science ®Google Scholar
• Stenson W F. Leukotriene B4 in inflammatory bowel disease. Inflammatory bowel diseases, H Goebel. MTP Press, Lancaster 1988; 143
   Google Scholar
• Czarnetzki B M, Rosenbach T. From eosinophil chemotactic factor of anaphylaxis to leukotriene B4-chemistry, biology, and functional significance of eosinophil chemotactic leukotrienes in dermatology. Dermatologica 1989; 179(suppl 1)54–59
   PubMedGoogle Scholar
• Jones D G, Kay A B. Chemical and biological properties of eosinophils and their chemotactic factors. Behring Inst Mitt 1975; 57: 98–102
   Google Scholar
• Macdermott R P, Stenson W F. Alterations of the immune system in ulcerative colitis and Crohn's disease. Adv Immunol 1988; 42: 285–328
   PubMed Web of Science ®Google Scholar
• Walsh R E, Keith R L, Tsai B S, Gaginella T S. Characterization of leukotriene B4 (LTB4) receptors on human eosinophils. FASEB J 1991; 5: A547
   Google Scholar
• Tsai B S, Villani-Price D, Keith R H, et al. SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions. Prostaglandins 1989; 38: 655–674
   PubMed Web of Science ®Google Scholar
• Villani-Price D, Yang D C, Walsh R E, et al. Multiple actions of the leukotriene B4 receptor antagonist SC-41930. J Pharmacol Exp Ther 1991, In press
   Google Scholar
• Fretland D J, Levin S, Tsai B S, et al. Effect of leukotriene B4 receptor antagonist, SC-41930, on acetic acid-induced colon inflammation. Agents Actions 1989; 27: 395–397
   PubMedGoogle Scholar
• Eliakin R, Karmeli F, Razin E, Rachmilewitz D. Role of platelet-activating factor in ulcerative colitis. Gastroenterology 1988; 95: 1167–1172
   PubMedGoogle Scholar